Charles Loprinzi on Potential Treatments for Chemotherapy-Induced Peripheral Neuropathy
Charles Loprinzi, MD, Giant of Cancer Care: Supportive/Palliative Care, Mayo Clinic, discusses potential treatments for chemotherapy-induced peripheral neuropathy (CIPN).
Charles Loprinzi, MD, Giant of Cancer Care: Supportive/Palliative Care, Mayo Clinic, discusses potential treatments for chemotherapy-induced peripheral neuropathy (CIPN).
Duloxetine has demonstrated benefits in managing CIPN in clinical trials, but Loprinzi adds that the benefits are not great and the drug is associated with some toxicities.Â
Loprinzi says minocycline, which is commonly used to treat acne, has promising preclinical data in preventing neuropathy. Pilot studies for the drug are ongoing.Â
Another method being tested for the treatment of CIPN is Scrambler therapy, in which electrodes are placed on the skin in areas around sites of pain. Electrical signals send non-pain messages to areas that are interpreting chronic pain, such as that caused by neuropathy. This therapy has not been proven effective in treating CIPN, but Loprinzi says that he is convinced it can help a number of patients in this population.Â
Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers
September 1st 2022In this episode of "The Vitals," Sarah Donahue, MPH, NP, AOCNP; Jamie Carroll, APRN, CNP, MSN; Theresa Wicklin Gillespie, PhD, MA, RN, FAAN; and Elizabeth Prechtel-Dunphy, DNP, RN, ANP-BC, AOCN, exchange clinical pearls for treating patients receiving antibody-drug conjugates.
Increasing Awareness of Audiovestibular Adverse Events From Immune Checkpoint Inhibitors
July 16th 2024Oncology nurses play a critical role in identifying and managing rare audiovestibular complications associated with immune checkpoint inhibitors to prevent permanent hearing loss and improve patients' quality of life.
